To gain a deeper understanding of the relevance and underlying mechanisms of the innate immune pathway in cholangiocarcinoma, we investigated the expression levels of DDX58, MAVS, C6orf150, TMEM173, IKBKE, TBK1, and IRF3 in different cell types using the TISCH2 database. Here, RIGI is linked to cholangiocarcinoma.